J Infect Dis. 1994 Jul;170(1):51-9.

Prolonged clinical latency and survival of macaques given a whole inactivated simian immunodeficiency virus vaccine.

Hirsch VM, Goldstein S, Hynes NA, Elkins WR, London WT, Zack PM, Montefiori D, Johnson PR.

Source

Immunodeficiency Viruses Section, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.

Abstract

Simian immunodeficiency virus (SIV) infection of macaques is a useful and relevant model for evaluating candidate human immunodeficiency virus (HIV) vaccines. One important feature of this model is that SIV vaccines can be evaluated for their ability to prevent infection as well as to prevent or delay the onset of AIDS. In the present study, a group of macaques was vaccinated with whole inactivated SIV and challenged with peripheral blood mononuclear cells from an SIV-infected macaque. This challenge represented a rigorous and realistic test of the immunization protocol. All macaques became infected after challenge; however, immunized animals survived significantly longer (P < .03) than naive controls. These data suggest that similar vaccines administered to humans at risk for HIV-1 infection might delay or prevent AIDS even if the vaccine failed to prevent infection.

PMID:: 8014520; [PubMed - indexed for MEDLINE]

LinkOut - more resources

Full Text Sources

Medical

HIV InSite

Supplemental Content

Related citations

Protection against lethal simian immunodeficiency virus SIVsmmPBj14 disease by a recombinant Semliki Forest virus gp160 vaccine and by a gp120 subunit vaccine. [J Virol. 1996]
Protection against lethal simian immunodeficiency virus SIVsmmPBj14 disease by a recombinant Semliki Forest virus gp160 vaccine and by a gp120 subunit vaccine.
Mossman SP, Bex F, Berglund P, Arthos J, O'Neil SP, Riley D, Maul DH, Bruck C, Momin P, Burny A, et al. J Virol. 1996 Mar; 70(3):1953-60.
Immunization of macaques with live simian human immunodeficiency virus (SHIV) vaccines conferred protection against AIDS induced by homologous and heterologous SHIVs and simian immunodeficiency virus. [Virology. 2002]
Immunization of macaques with live simian human immunodeficiency virus (SHIV) vaccines conferred protection against AIDS induced by homologous and heterologous SHIVs and simian immunodeficiency virus.
Kumar A, Mukherjee S, Shen J, Buch S, Li Z, Adany I, Liu Z, Zhuge W, Piatak M Jr, Lifson J, et al. Virology. 2002 Sep 30; 301(2):189-205.
Vaccine protection of rhesus macaques against simian immunodeficiency virus infection. [AIDS Res Hum Retroviruses. 1990]
Vaccine protection of rhesus macaques against simian immunodeficiency virus infection.
Carlson JR, McGraw TP, Keddie E, Yee JL, Rosenthal A, Langlois AJ, Dickover R, Donovan R, Luciw PA, Jennings MB. AIDS Res Hum Retroviruses. 1990 Nov; 6(11):1239-46.
Review SIV vaccines: current status. The role of the SIV-macaque model in AIDS research. [Vaccine. 1991]
Review SIV vaccines: current status. The role of the SIV-macaque model in AIDS research.
Gardner M. Vaccine. 1991 Nov; 9(11):787-91.
Review Simian and feline immunodeficiency viruses: animal lentivirus models for evaluation of AIDS vaccines and antiviral agents. [Antiviral Res. 1991]
Review Simian and feline immunodeficiency viruses: animal lentivirus models for evaluation of AIDS vaccines and antiviral agents.
Gardner MB. Antiviral Res. 1991 May; 15(4):267-86.

See reviews... See all...

Cited by 11 PubMed Central articles

Mamu-A01/K(b) transgenic and MHC Class I knockout mice as a tool for HIV vaccine development. [Virology. 2009]
Mamu-A01/K(b) transgenic and MHC Class I knockout mice as a tool for HIV vaccine development.
Li J, Srivastava T, Rawal R, Manuel E, Isbell D, Tsark W, La Rosa C, Wang Z, Li Z, Barry PA, et al. Virology. 2009 Apr 25; 387(1):16-28. Epub 2009 Feb 27.
Infectious molecular clones from a simian immunodeficiency virus-infected rapid-progressor (RP) macaque: evidence of differential selection of RP-specific envelope mutations in vitro and in vivo. [J Virol. 2006]
Infectious molecular clones from a simian immunodeficiency virus-infected rapid-progressor (RP) macaque: evidence of differential selection of RP-specific envelope mutations in vitro and in vivo.
Kuwata T, Dehghani H, Brown CR, Plishka R, Buckler-White A, Igarashi T, Mattapallil J, Roederer M, Hirsch VM. J Virol. 2006 Feb; 80(3):1463-75.
Effects of cytotoxic T lymphocytes (CTL) directed against a single simian immunodeficiency virus (SIV) Gag CTL epitope on the course of SIVmac239 infection. [J Virol. 2002]
Effects of cytotoxic T lymphocytes (CTL) directed against a single simian immunodeficiency virus (SIV) Gag CTL epitope on the course of SIVmac239 infection.
Allen TM, Jing P, Calore B, Horton H, O'Connor DH, Hanke T, Piekarczyk M, Ruddersdorf R, Mothé BR, Emerson C, et al. J Virol. 2002 Oct; 76(20):10507-11.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Taxonomy via GenBank
Taxonomy records associated with the current articles through taxonomic information on related molecular database records (Nucleotide, Protein, Gene, SNP, Structure).
Protein
Protein translation features of primary database (GenBank) nucleotide records reported in the current articles as well as Reference Sequences (RefSeqs) that include the articles as references.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.
Cited in Books
NCBI Bookshelf books that cite the current articles.

Recent activity

Clear Turn Off Turn On

Prolonged clinical latency and survival of macaques given a whole inactivated si...
Prolonged clinical latency and survival of macaques given a whole inactivated simian immunodeficiency virus vaccine.
J Infect Dis. 1994 Jul ;170(1):51-9.

PubMed
Deep penetrating nevus.
Deep penetrating nevus.
Am J Surg Pathol. 1989 Jan ;13(1):39-44.

PubMed
Impetigo. Current etiology and comparison of penicillin, erythromycin, and cepha...
Impetigo. Current etiology and comparison of penicillin, erythromycin, and cephalexin therapies.
Am J Dis Child. 1990 Dec ;144(12):1313-5.

PubMed
Double-blind, double-dummy comparison of azithromycin and cephalexin in the trea...
Double-blind, double-dummy comparison of azithromycin and cephalexin in the treatment of skin and skin structure infections.
Eur J Clin Microbiol Infect Dis. 1991 Oct ;10(10):880-4.

PubMed
Mechanism of viroid pathogenesis: differential activation of the interferon-indu...
Mechanism of viroid pathogenesis: differential activation of the interferon-induced, double-stranded RNA-activated, M(r) 68,000 protein kinase by viroid strains of varying pathogenicity.
Biochimie. 1993 ;75(7):533-8.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to:

Prolonged clinical latency and survival of macaques given a whole inactivated simian immunodeficiency virus vaccine.

Source

Abstract

MeSH Terms, Substances

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Supplemental Content

Related citations

Cited by 11 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information